Needham analyst Serge Belanger initiated coverage of Ocular Therapeutix (OCUL) with a Buy rating and $15 price target citing Axpaxli’s ...
As part of the campaign, NBK is raising awareness among customers about fraudulent schemes targeting Instant Payment Service (WAMD). The bank underscores the importance of recognizing these tactics ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果